{"ORPHApacket":[{"ORPHApacketID":"19","date":"2019-07-19 09:14:08","version":"1.2.11 \/ 4.1.6 [2018-04-12] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"19","Name":[{"lang":"en","label":"2-hydroxyglutaric aciduria"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_19","DisorderType":[{"Name":[{"lang":"en","label":"Group of phenomes"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377794"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Neurometabolic disease"}],"ORPHA":"68385","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_68385"},{"Name":[{"lang":"en","label":"Cerebral organic aciduria"}],"ORPHA":"79158","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_79158"},{"Name":[{"lang":"en","label":"Amino acid or protein metabolism disease with epilepsy"}],"ORPHA":"225689","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_225689"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Disease definition"}],"Contents":"2-Hydroxyglutaric aciduria is a group of neurometabolic disorders with a wide clinical spectrum ranging from severe neonatal presentations to progressive forms, and asymptomatic cases, characterized biochemically by increased levels of 2-hydroxyglutaric acid in the plasma, cerebrospinal fluid and urine."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]}]}],"TypeOfInheritanceList":[{"count":"2","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal dominant"}]},{"Name":[{"lang":"en","label":"Autosomal recessive"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"2-hydroxyglutaric acidemia"}]}]}]}